Thamilarasan V, Sengottuvelan N, Sudha A, Srinivasan P, Siva A
Department of Industrial Chemistry, Alagappa University, Karaikudi 630 003, India.
Department of Chemistry, Directorate of Distance Education, Alagappa University, Karaikudi 630 003, India.
J Photochem Photobiol B. 2015 Jan;142:220-31. doi: 10.1016/j.jphotobiol.2014.12.001. Epub 2014 Dec 22.
Manganese(III) complex (1) [Mn(8-hq)3] (where 8-hq=8-hydroxyquinoline) has been synthesized and characterized by elemental, spectral (UV-vis, FT-IR) and thermal analysis. The structure of complex (1) has been determined by single crystal X-ray diffraction studies and the configuration around manganese(III) ion was elongated octahedral coordination geometry. Density functional theory calculations were performed for ligand and its complex. Binding studies of ligand and complex 1 with calf thymus DNA (CT-DNA) was investigated by absorption, fluorescence, circular dichroic (CD) spectroscopy and viscosity measurements. Absorption spectral studies revealed that ligand and complex 1 binds to DNA groove and its intrinsic binding strength has been found to be 2.57×10(4) and 2.91×10(4)M(-1). A molecular docking study confirm that the complex 1 is a minor groove binder and was stabilized through hydrogen bonding interactions. Complex 1 exhibits a good binding propensity to bovine serum albumin (BSA) protein. The in vitro cytotoxicity study of complex 1 on breast cancer cell line (MCF-7) indicate that it has the potential to act as effective anticancer drug, with IC50 values of 3.25μM. The ligand and its complex have been screened for antimicrobial activities and the complex showed better antimicrobial activity than the free ligand.
已合成锰(III)配合物(1)[Mn(8 - hq)3](其中8 - hq = 8 - 羟基喹啉),并通过元素分析、光谱分析(紫外可见光谱、傅里叶变换红外光谱)和热分析对其进行了表征。通过单晶X射线衍射研究确定了配合物(1)的结构,锰(III)离子周围的构型为拉长八面体配位几何结构。对配体及其配合物进行了密度泛函理论计算。通过吸收光谱、荧光光谱、圆二色光谱(CD)和粘度测量研究了配体和配合物1与小牛胸腺DNA(CT - DNA)的结合情况。吸收光谱研究表明,配体和配合物1与DNA沟槽结合,其固有结合强度分别为2.57×10(4)和2.91×10(4)M(-1)。分子对接研究证实配合物1是一种小沟结合剂,并通过氢键相互作用得以稳定。配合物1对牛血清白蛋白(BSA)蛋白表现出良好的结合倾向。配合物1对乳腺癌细胞系(MCF - 7)的体外细胞毒性研究表明,它有潜力作为有效的抗癌药物,IC50值为3.25μM。对配体及其配合物进行了抗菌活性筛选,配合物显示出比游离配体更好的抗菌活性。